You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The genetic testing company said its orders for traditional tests have also rebounded and are on track for growth in the second half of 2020.
The next iteration of Ancestry's Health experience seeks to provide customers with actionable information about certain commonly inherited health conditions.
Consumer Reports points out a regulatory gap in the US surrounding direct-to-consumer genetic tests that it says lawmakers should address.
Stat News offers ways consumer genetic testing companies could address racial disparities.
The investment bank gave shares of the Temple City, California-based genetic testing company a buy rating and a $20 price target.
Genos customers have until June 22 to dowload their exome and variant data from the Genos portal before it will no longer be accessible.
Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.
Fulgent saw a 75 percent increase year over year in billable tests, leading to revenues of $7.8 million. It also withdrew its 2020 full-year revenue guidance.
Data collected from volunteers will be used in a genome-wide association study to better understand COVID-19.
Some of the market's most influential voices, including Kári Stefánsson and Linda Avey, believe that consumer genomics is not on the way out but rather experiencing a period of transition.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.